Furthermore, abnormally high expression of FGF23 in patients with chronic renal failure accelerates a series of extrarenal damages such as organismal calciphylaxis, atherosclerosis, secondary bone disease, and cognitive impairment of the nervous system [11–13]. This evidence concerns the gene FGF23 and chronic kidney disease.